Dr Andy Richards CBE is an entrepreneur specialising in healthcare and life sciences. He is currently Chairman of Arecor Limited, Congenica Limited, Abcodia Limited and Novacta Biosystems Limited as well as being a Director of Silence Therapeutics plc, Ieso Digital Health Limited and Sensiia Limited. He was a founder of Chiroscience Group plc and an executive director through its merger with Celltech plc in 1999.
Andy has a track record as a founder, director and active investor in more than 25 innovative healthcare and life science companies., including Vectura and Arakis. He is Chariman of Babraham Bioscience Technologies (the Babraham Campus), a director of Cancer Research Technologies, and a member of CRUK. Andy is a graduate of the University of Cambridge with a PhD in Chemistry and is also a founder member of the Cambridge Angels.